{
    "nct_id": "NCT06501989",
    "official_title": "A Pilot Study of Pharmacokinetically (PK) Dose Adjusted 5-Fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer",
    "inclusion_criteria": "* Males or females at least 18 years of age.\n* Histologically confirmed metastatic colorectal cancer eligible for treatment with 5-FU.\n* No prior therapy for metastatic disease. If adjuvant 5-FU or FOLFOX was administered, the last dose must have been at least 6 months prior to the diagnosis of metastatic disease.\n* Adequate organ function.\n* Eastern Cooperative Oncology Group (ECOG) status less than or equal to 2.\n* Life expectancy > 3 months.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Untreated brain metastasis. Treated brain metastases are allowed as long as symptoms have resolved off of steroids.\n* At least 4 weeks from any prior surgery or 2 weeks from radiation treatments.\n* Known dihydropyrimidine dehydrogenase (DPD) deficiency.",
    "miscellaneous_criteria": ""
}